Abstract
Background
Primary percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (STEMI) improves outcome in comparison to fibrinolysis. However, it is unclear whether patients treated in interventional facilities with 24-h primary PCI service have lower rates of adverse events.
Methods
We analyzed data of consecutive patients with STEMI prospectively enrolled in the German Acute Coronary Syndromes registry between July 2000 and November 2002 who were admitted to hospitals with catheterisation laboratory.
Results
Overall 6,350 patients were divided into two groups: 2,779 (43.8%) were treated in hospitals with and 3,571 (56.2%) without 24-h on-call cardiac catheter laboratories. 83.0% of the patients at facilities with and only 69.9% of the patients at facilities without 24-h PCI service received early reperfusion therapy (P < 0.001). Hospital death (7.4% vs. 9.9%, P < 0.001), non-fatal myocardial reinfarction (2.5% vs. 6.4%, P < 0.0001) and stroke (0.3 vs. 1.0%, P < 0.01) occurred significantly less often in patients treated in hospitals with 24-h primary PCI service. After adjustment for the confounding factors in the propensity score analysis the 24-h on-call strategy remained superior for the combined endpoint of death, reinfarction and stroke (OR 0.63, 95% CI 0.54–0.75).
Conclusions
In clinical practice the rate of patients receiving reperfusion therapy was significantly higher in hospitals with 24-h primary PCI service which was associated with an improved in-hospital outcome. Though the data was collected at a time that does not completely represent current clinical practice, these results could have an impact on planning efficient infarct networks in the future.
Similar content being viewed by others
References
Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Ornato JP (2004) ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task force on Practice Guidelines (Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 44:E1–E211
Canto JG, Every NR, Magid DJ, Rogers WJ, Malmgren JA, Frederick PD, French WJ, Tiefenbrunn AJ, Misra VK, Kiefe CI, Barron HV (2000) The volume of primary angioplasty procedures and survival after acute myocardial infarction. N Engl J Med 342:1573–1580
D’Agostino RB Jr (1998) Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17:2265–2281
Eagle KA, Goodman SG, Avezum A, Budaj A, Sullivan CM, Lopez-Sendon J, GRACE Investigators (2002) Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from global registry of acute coronary events (GRACE). Lancet 359:373–377
Every NR, Larson EB, Litwin PE, Maynard C, Fihn SD, Eisenberg MS, Hallstrom AP, Martin JS, Weaver WD (1993) The association between on-site cardiac catherization facilities and the use of coronary angiography after acute myocardial infarction. NEJM 329:546–551
Every NR, Parsons LS, Fihn SD, Larson EB, Maynard C, Hallstrom AP, Martin JS, Weaver WD (1997) Long-term outcome in acute myocardial infarction patients admitted to hospitals with and without on-site cardiac catheterisation facilities. Circulation 96:1770–1775
Gibson CM, Cannon CP, Murphy SA, Ryan KA, Mesley R, Marble SJ, McCabe CH, Van De Werf, Braunwald E (2000) Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 101:125–130
Hochman JS, Sleeper L, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 341:625–634
Juliard JM, Himbert D, Golmard JL, Aubry P, Karrilon GJ, Boccara A, Benamer H, Steg PG (1997) Can we provide reperfusion therapy to all unselected patients admitted with acute myocardial infarction? J Am Coll Cardiol 30:157–164
Keeley EC, Boura JA, Grines CL (2003) Primary angioplasty vs. intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361:13–20
Khadour FH, Fu Y, Chang WC, Ma X, Mark D, Granger CB, Topol EJ, Califf RM, Armstrong PW (2003) Impact of on-site cardiac interventional facilities on management and outcome of patients with acute coronary syndromes. Can J Cardiol 19:257–263
Krumholz HM, Chen J, Murillo JE, Cohen DJ, Radford MJ (1998) Admission to hospitals with on-site cardiac catheterisation facilities: impact on long-term costs and outcomes. Circulation 98:2010–2016
Krüth P, Zeymer U, Jünger C, Wienbergen H, Niedermeier F, Glunz HG, Senges J, Zahn R (2008) Influence of presentation at the weekend on treatment and outcome in ST-elevation myocardial infarction in hospitals with catheterisation laboratories. Clin Res Cardiol 97:742–747
Labarere J, Belle L, Fourny M, Genes N, Lablanche JM, Blanchard D, Cambou JP, Danchin N (2007) Outcomes of myocardial infarction in hospitals with percutaneous coronary intervention facilities. Arch Intern Med 167:913–920
Moosvi AR, Khaja F, Villanueva L, Gheorghiade M, Douthat L, Goldstein S (1992) Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 19:907–914
Morrow DA, Antman EM, Parsons L, de Lemos JA, Cannon CP, Giugliano RP, McCabe CH, Barron HV, Braunwald E (2001) Application of the TIMI risk score for ST-elevation MI in the national registry of myocardial infarction 3. JAMA 286:1356–1359
Moscucci M, Share D, Smith D, O’Donnell MJ, Riba A, McNamara R, Lalonde T, Defranco AC, Patel K, Rogers EK, D’Haem C, Karve M, Eagle KA (2005) Relationship between operator volume and adverse outcome in contemporary percutaneous coronary intervention practice. J Am Coll Cardiol 46:625–632
Natarajan MK, Yusuf S (2003) Primary angioplasty for ST-segment elevation myocardial infarction: Ready for prime time? CMAJ 169:32–35
Rogers WJ, Canto JG, Barron HV, Boscarino JA, Shoultz DA, Every NR (2000) Treatment and outcome of myocardial infarction in hospitals with and without invasive capability. J Am Coll Cardiol 35:371–379
Spaulding C, Morice MC, Lancelin B, El Haddad S, Lepage E, Bataille S, Tresca JP, Mouranche X, Fosse S, Monchi M, de Vernejoul N; CARDIO-ARIF Registry Investigators (2006) Is the volume-outcome relation still an issue in the era of PCI with systematic stenting? Results of the greater Paris area PCI registry. Eur Heart J 9:1054–1060
Stone GW, Grines CL, Browne KF, Marco J, Rothbaum D, O’Keefe JH, Hartzler GO, Overlie P, Donohue B, Chelliah N, Vliestra R, Puchromicz-Ochocki S, O’Neill WW, for the Primary Angioplasty in Myocardial Infarction (PAMI) Investigators (1996) Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Cath Cardiovasc Diagn 39:333–339
The GUSTO Angiographic Investigators (1993) The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 329:1615–1622
Van de Werf F, Gore JM, Avezum A, Gulba DC, Goodman SG, Budaj A, Brieger D, White K, Fox KA, Eagle KM, Kennelly BM (2005) Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study. BMJ 330:441–446
Weaver WD, Simes RJ, Betriu A, Grines CL, Zijlstra F, Garcia E, Grinfeld L, Gibbons RJ, Ribeiro EE, DeWood MA, Ribichini F (1997) Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. JAMA 278:2093–2098
Zahn R, Schuster S, Schiele R, Seidl K, Voigtlander T, Meyer J, Hauptmann KE, Gottwik M, Berg G, Kunz T, Gieseler U, Jakob M, Senges J (1999) Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy: maximal individual therapy in acute myocardial infarction (MITRA) study group. Catheter Cardiovasc Interv 46:127–133
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bauer, T., Hoffmann, R., Jünger, C. et al. Efficacy of a 24-h primary percutaneous coronary intervention service on outcome in patients with ST elevation myocardial infarction in clinical practice. Clin Res Cardiol 98, 171–178 (2009). https://doi.org/10.1007/s00392-008-0738-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-008-0738-6